Enhanced parasympathetic activity in Chagas disease still stands in need of proof

Antonio Luiz P Ribeiro, Antonio Carlos Campos de Carvalho, Federico Lombardi, Mauro Martins Teixeira, Manoel Otávio Costa Rocha

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Cardiac vagal modulation impairment is a typical feature of Chagas disease (ChD) and is correlated to antagonistic anti-M2 autoantibodies activity. In this letter, we analyze the hypothesis that, in ChD, anti-muscarinic antibody activity could simultaneously increase parasympathetic tonus (decreasing heart rate) and decrease vagal modulation over cardiac sinus node (reducing heart rate variability - HRV). Although attractive, this hypothesis is not supported by empirical data, since reduction of vagal-specific HRV indexes has been demonstrated in the absence of bradycardia. Moreover, anti-muscarinic antibody levels correlate with HRV indexes, but not with heart rate. In the absence of reduced heart rate and, consequently, of tonic vagal enhancement, it is impossible to explain the reduction of vagal-mediated HRV by continuous and strong muscarinic activity of autoantibodies in ChD.

Original languageEnglish
Pages (from-to)406-408
Number of pages3
JournalInternational Journal of Cardiology
Volume135
Issue number3
DOIs
Publication statusPublished - Jul 10 2009

Fingerprint

Chagas Disease
Heart Rate
Cholinergic Agents
Autoantibodies
Anti-Idiotypic Antibodies
Sinoatrial Node
Bradycardia

Keywords

  • Autonomic nervous system
  • Chagas disease
  • Heart rate variability

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Enhanced parasympathetic activity in Chagas disease still stands in need of proof. / Ribeiro, Antonio Luiz P; de Carvalho, Antonio Carlos Campos; Lombardi, Federico; Teixeira, Mauro Martins; Rocha, Manoel Otávio Costa.

In: International Journal of Cardiology, Vol. 135, No. 3, 10.07.2009, p. 406-408.

Research output: Contribution to journalArticle

Ribeiro, Antonio Luiz P ; de Carvalho, Antonio Carlos Campos ; Lombardi, Federico ; Teixeira, Mauro Martins ; Rocha, Manoel Otávio Costa. / Enhanced parasympathetic activity in Chagas disease still stands in need of proof. In: International Journal of Cardiology. 2009 ; Vol. 135, No. 3. pp. 406-408.
@article{048e13db039443b2b6a45f0643c7908c,
title = "Enhanced parasympathetic activity in Chagas disease still stands in need of proof",
abstract = "Cardiac vagal modulation impairment is a typical feature of Chagas disease (ChD) and is correlated to antagonistic anti-M2 autoantibodies activity. In this letter, we analyze the hypothesis that, in ChD, anti-muscarinic antibody activity could simultaneously increase parasympathetic tonus (decreasing heart rate) and decrease vagal modulation over cardiac sinus node (reducing heart rate variability - HRV). Although attractive, this hypothesis is not supported by empirical data, since reduction of vagal-specific HRV indexes has been demonstrated in the absence of bradycardia. Moreover, anti-muscarinic antibody levels correlate with HRV indexes, but not with heart rate. In the absence of reduced heart rate and, consequently, of tonic vagal enhancement, it is impossible to explain the reduction of vagal-mediated HRV by continuous and strong muscarinic activity of autoantibodies in ChD.",
keywords = "Autonomic nervous system, Chagas disease, Heart rate variability",
author = "Ribeiro, {Antonio Luiz P} and {de Carvalho}, {Antonio Carlos Campos} and Federico Lombardi and Teixeira, {Mauro Martins} and Rocha, {Manoel Ot{\'a}vio Costa}",
year = "2009",
month = "7",
day = "10",
doi = "10.1016/j.ijcard.2008.03.030",
language = "English",
volume = "135",
pages = "406--408",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Enhanced parasympathetic activity in Chagas disease still stands in need of proof

AU - Ribeiro, Antonio Luiz P

AU - de Carvalho, Antonio Carlos Campos

AU - Lombardi, Federico

AU - Teixeira, Mauro Martins

AU - Rocha, Manoel Otávio Costa

PY - 2009/7/10

Y1 - 2009/7/10

N2 - Cardiac vagal modulation impairment is a typical feature of Chagas disease (ChD) and is correlated to antagonistic anti-M2 autoantibodies activity. In this letter, we analyze the hypothesis that, in ChD, anti-muscarinic antibody activity could simultaneously increase parasympathetic tonus (decreasing heart rate) and decrease vagal modulation over cardiac sinus node (reducing heart rate variability - HRV). Although attractive, this hypothesis is not supported by empirical data, since reduction of vagal-specific HRV indexes has been demonstrated in the absence of bradycardia. Moreover, anti-muscarinic antibody levels correlate with HRV indexes, but not with heart rate. In the absence of reduced heart rate and, consequently, of tonic vagal enhancement, it is impossible to explain the reduction of vagal-mediated HRV by continuous and strong muscarinic activity of autoantibodies in ChD.

AB - Cardiac vagal modulation impairment is a typical feature of Chagas disease (ChD) and is correlated to antagonistic anti-M2 autoantibodies activity. In this letter, we analyze the hypothesis that, in ChD, anti-muscarinic antibody activity could simultaneously increase parasympathetic tonus (decreasing heart rate) and decrease vagal modulation over cardiac sinus node (reducing heart rate variability - HRV). Although attractive, this hypothesis is not supported by empirical data, since reduction of vagal-specific HRV indexes has been demonstrated in the absence of bradycardia. Moreover, anti-muscarinic antibody levels correlate with HRV indexes, but not with heart rate. In the absence of reduced heart rate and, consequently, of tonic vagal enhancement, it is impossible to explain the reduction of vagal-mediated HRV by continuous and strong muscarinic activity of autoantibodies in ChD.

KW - Autonomic nervous system

KW - Chagas disease

KW - Heart rate variability

UR - http://www.scopus.com/inward/record.url?scp=67449147044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67449147044&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2008.03.030

DO - 10.1016/j.ijcard.2008.03.030

M3 - Article

C2 - 18599135

AN - SCOPUS:67449147044

VL - 135

SP - 406

EP - 408

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 3

ER -